Fractional Exhaled Nitric Oxide (FeNO) Result Prediction Factors in Children With Allergic Diseases

Completed

• Conditions: Asthma; Allergic Rhinitis; Atopic Dermatitis

• Registration Number: NCT00815984
• Lead Sponsor: Medical University of Lodz

Brief Summary

In about 800 children with allergic diseases (asthma, allergic rhinitis, atopic dermatitis) the investigators will retrospectively and cross-sectionally analyze the influence/correlation of diagnosis, treatment methods, allergy status (skin prick test results), lung function tests results on/with the concentration of nitric oxide in exhaled breath.

Detailed Description

In about 800 children with allergic diseases from our Outpatient Clinic (asthma, allergic rhinitis, atopic dermatitis) we will retrospectively and cross-sectionally analyse the influence/correlation of diagnosis, treatment methods, allergy status (skin prick test results), lung function tests results on/with the concentration of nitric oxide in exhaled breath.

Study Timeline

• Study First Submitted: 2008-12-30
• Study First Submitted QC: 2008-12-30
• Study First Posted: 2008-12-31
• Study Start: 2009-01
• Primary Completion: 2010-01
• Study Completion: 2010-01
• Status Verified: 2010-02
• Last Update Submitted: 2010-02-09
• Last Update Posted: 2010-02-10

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 800

Inclusion Criteria

• Children with asthma (allergic), and/or allergic rhinitis and/or atopic dermatitis

Exclusion Criteria

• Other chronic diseases
• Asthma exacerbation
• Pregnancy

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Concentration of nitric oxide in exhaled breath.	1-4 months

Trial Locations

Locations (1)

Department of Pediatrics and Allergy, N. Copernicus Hospital; 🇵🇱 Lodz, Poland